Skip to main content

Table 2 Summary of results from studies reporting anti-HCV prevalence in pregnant women and first-time blood donors

From: Prevalence of hepatitis C infection among the general population and high-risk groups in the EU/EEA: a systematic review update

Author, year

Country

Recruiting period

Population as reported

Age, mean (SD)

Sample size

Anti-HCV prevalence (%) (95% CI)

Risk of selection bias

Pregnant women

 Orkin, 2016 [30]

UK

2013

Women who attended antenatal clinics during 2013 at 2 London hospitals

–

1000

0.50 (0.06–0.94)

High risk

 Cortina-Borja, 2016 [31]

UK

1 April–30 June 2012

Women delivering live-born infants in the North Thames region in England

–

31467

0.10 (0.07–0.14)

Low risk

 Kopilovic, 2015 [32]

Slovenia

1999, 2003, 2009 and 2013

Pregnant women

–

31849

0.13 (0.09–0.17)

Low risk

 Lembo, 2017 [33]

Italy

January 2010–December 2015

Pregnant women consecutively admitted to the Division of Obstetrics and Gynaecology of the University Hospital of Messina, Italy

–

5184

0.20 (−)

High risk

 Walewska-Zielecka, 2016 [34]

Poland

2004–2014

Pregnant women in Poland

33.4(7.9)

42274

1.32 (−)

Low risk

 Millbourn, 2017 [35]

Sweden

October 2013–March 2015 and

October 2013–February 2016

Every pregnant woman and her partner in Orebro county and in Southern part of Stockholm (288,000 and 300,000 inhabitants, respectively)

–

21379

0.20* (−)

Low risk

 Munoz-Gamez, 2016 [36]

Spain

January–October 2015

Pregnant women in Spain

–

−

0.55 (0.55–0.77)

Low risk

First-time blood donors

 Velati, 2018 [37]

Italy

January 2009–December 2015

Voluntary, unpaid first-time donors

–

1934612

0.09 (0.08–0.09)

Low risk

 Politis, 2018 [38]

Greece

2010–2016

Blood donor

–

−

0.03 (−)

High risk

  1. *calculated based on available data